GSK and Daiichi Sankyo JV submits NDA for candidate shingles vaccine in Japan

GlaxoSmithKline (GSK) and Daiichi Sankyo joint venture (JV) Japan Vaccine Co has submitted a New Drug Application (NDA) in Japan for candidate shingles vaccine, Shingrix.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news